Biology of EPO, - Classification and characterization of anemia in cancera, - Pathophysiology of cancer-related anemia, - Prevalence, pathophysiology, predictive factors, and prognostic significance of anemia in cancer chemotherapy, - Incidence and impact of anemia in radiation oncology, - Relationship between anemia and tumor hypoxia, - Tumor hypoxia and therapeutic resistance, - Impact of anemia on organ functions, - Relationship between anemia, fatigue, and quality of life in cancer patients, - Red blood transfusions, ...
Read More
Biology of EPO, - Classification and characterization of anemia in cancera, - Pathophysiology of cancer-related anemia, - Prevalence, pathophysiology, predictive factors, and prognostic significance of anemia in cancer chemotherapy, - Incidence and impact of anemia in radiation oncology, - Relationship between anemia and tumor hypoxia, - Tumor hypoxia and therapeutic resistance, - Impact of anemia on organ functions, - Relationship between anemia, fatigue, and quality of life in cancer patients, - Red blood transfusions, risks and limitations, - Pharmacology, pharmacokinetics and safety of rhEPO, - rhEPO in anemia associated with multiple myeloma and non-Hodgkin lymphoma, - Use of rhEPO in the treatment of myelodysplastic syndromes, - rhEPO in anemia associated with solid tumors and chemotherapy, - Predictive factors for response of anemia to rhEPO, - rhEPO in hematopoietic stem cell mobilization, transplantation, and in-vitro expansion, - Clinical trials using rhEPO in radiation oncology, - rhEPO in pediatric oncology, - rhEPO in surgical oncology, - Erythropoiesis, iron metabolism and iron supplementation during erythropoietin therapy, - Optimal level of hemoglobin in cancer patients, - Protection of metabolic and exercise capacity following treatment with rhEPO, - Effects of treatment with rhEPO on quality of life in anemic cancer patients, - Effect of rhEPO on survival in anemic cancer patients receiving chemotherapy, - Cost-effectiveness of treatment with rhEPO in oncology, - Current status and future develo of rhEPO in clinical oncology, - Subject Index.
Read Less
Add this copy of Recombinant Human Erythropoietin (Rhepo) in Clinical to cart. $78.91, new condition, Sold by discount_scientific_books rated 4.0 out of 5 stars, ships from Sterling Heights, MI, UNITED STATES, published 2002 by Springer.
Add this copy of Recombinant Human Erythropoietin (Rhepo) in Clinical to cart. $108.94, new condition, Sold by Media Smart rated 4.0 out of 5 stars, ships from Hawthorne, CA, UNITED STATES, published 2002 by Springer.
Add this copy of Recombinant Human Erythropoietin (Rhepo) in Clinical to cart. $121.43, good condition, Sold by Bonita rated 4.0 out of 5 stars, ships from Newport Coast, CA, UNITED STATES, published 2003 by Springer.
Add this copy of Recombinant Human Erythropoietin (Rhepo) in Clinical to cart. $168.12, new condition, Sold by Bonita rated 4.0 out of 5 stars, ships from Newport Coast, CA, UNITED STATES, published 2003 by Springer.
